320 related articles for article (PubMed ID: 17373268)
21. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
[TBL] [Abstract][Full Text] [Related]
22. Pentoxifylline improves haemoglobin and interleukin-6 levels in chronic kidney disease.
Ferrari P; Mallon D; Trinder D; Olynyk JK
Nephrology (Carlton); 2010 Apr; 15(3):344-9. PubMed ID: 20470305
[TBL] [Abstract][Full Text] [Related]
23. Double diagnostic meaning of serum transferrin receptor in hemodialysis patients: two case reports.
Passanante S; Diquattro M; Greco V; Li Cavoli G; Bono L; Palma B; Scola S; Faraci C; Rotolo U; Menozzi I
Lab Hematol; 2004; 10(2):61-4. PubMed ID: 15224760
[TBL] [Abstract][Full Text] [Related]
24. Analytical and biological variation in measures of anemia and iron status in patients treated with maintenance hemodialysis.
Van Wyck DB; Alcorn H; Gupta R
Am J Kidney Dis; 2010 Sep; 56(3):540-6. PubMed ID: 20638166
[TBL] [Abstract][Full Text] [Related]
25. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.
Barosi G; Merlo C; Palestra P; Liberato NL; Guarnone R; Di Dio F; Piazza V; Salvadeo A
Acta Haematol; 1993; 90(1):13-8. PubMed ID: 8237268
[TBL] [Abstract][Full Text] [Related]
26. [Iron deficiency is a common cause of bad response to epoetin treatment. It's important to follow iron status--not only the Hb value].
Wallerstedt SM; Ljungman S; Broms E; Andrén L
Lakartidningen; 2005 Sep 12-18; 102(37):2550-1, 2553-5. PubMed ID: 16200900
[TBL] [Abstract][Full Text] [Related]
27. Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
Katodritou E; Terpos E; Zervas K; Speletas M; Kapetanos D; Kartsios C; Verrou E; Banti A; Effraimidou S; Christakis J
Ann Hematol; 2007 May; 86(5):369-76. PubMed ID: 17375302
[TBL] [Abstract][Full Text] [Related]
28. Iron metabolism in rhEPO-treated hemodialysis patients.
Schaefer RM; Bahner U
Clin Nephrol; 2000 Feb; 53(1 Suppl):S65-8. PubMed ID: 10746809
[TBL] [Abstract][Full Text] [Related]
29. Comparison of reticulocyte hemoglobin equivalent with traditional markers of iron and erythropoiesis in pediatric dialysis.
Davidkova S; Prestidge TD; Reed PW; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2016 May; 31(5):819-26. PubMed ID: 26667237
[TBL] [Abstract][Full Text] [Related]
30. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
31. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
Thomas C; Thomas L
Lab Hematol; 2005; 11(1):14-23. PubMed ID: 15790548
[TBL] [Abstract][Full Text] [Related]
32. The challenges of using serum ferritin to guide i.v. iron treatment practices in patients on hemodialysis with anemia.
Easom A
Nephrol Nurs J; 2006; 33(5):543-51; quiz 552-3. PubMed ID: 17044438
[TBL] [Abstract][Full Text] [Related]
33. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
[TBL] [Abstract][Full Text] [Related]
34. IV iron use in patients with higher serum ferritin: case study on anemia in kidney disease.
Larson K
Nephrol Nurs J; 2008; 35(2):184-93; quiz 194-5. PubMed ID: 18472686
[TBL] [Abstract][Full Text] [Related]
35. Evaluating iron status in hemodialysis patients.
Enders HM
Nephrol Nurs J; 2002 Aug; 29(4):366-70. PubMed ID: 12224370
[TBL] [Abstract][Full Text] [Related]
36. [Concentration of ferritin, transferrin and iron as a markers of iron deficiency in healthy women in reproductive age].
Chełchowska M; Laskowska-Klita T; Leibschang J
Pol Merkur Lekarski; 2007 Jan; 22(127):25-7. PubMed ID: 17477085
[TBL] [Abstract][Full Text] [Related]
37. Anemia management among hemodyalisis patients at the University Hospital in Puerto Rico.
Ocasio HE; Diaz H; Cangiano JL; Báez R; Suárez E
Bol Asoc Med P R; 2014; 106(2):9-12. PubMed ID: 25065044
[TBL] [Abstract][Full Text] [Related]
38. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
Dukkipati R; Kalantar-Zadeh K
Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
[TBL] [Abstract][Full Text] [Related]
39. Reticulocyte haemoglobin content vs. soluble transferrin receptor and ferritin index in iron deficiency anaemia accompanied with inflammation.
Marković M; Majkić-Singh N; Ignjatović S; Singh S
Int J Lab Hematol; 2007 Oct; 29(5):341-6. PubMed ID: 17824914
[TBL] [Abstract][Full Text] [Related]
40. Supporting epoetin alfa stimulated erythropoiesis: identifying appropriate iron levels: case study of the anemic patient.
Sasak C
Nephrol Nurs J; 2000 Dec; 27(6):612-5. PubMed ID: 16649342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]